Results 181 to 190 of about 113,785 (252)

Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review

open access: yesBritish Journal of Pharmacology, Volume 183, Issue 9, Page 1779-1813, May 2026.
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos   +16 more
wiley   +1 more source

Fascinating single‐cell red algae: models for evolution and adaptation

open access: yesNew Phytologist, Volume 250, Issue 3, Page 1424-1437, May 2026.
Summary The unicellular red algae, Cyanidiophyceae, that diverged early during Archaeplastida (algal and plant) evolution, occupy a variety of extreme habitats that are inhospitable for most other eukaryotes. With the use of modern genomics and genetics methods, Cyanidiophyceae show a remarkable taxonomic diversity, share haplodiplophasic life cycles ...
Frédéric Berger   +13 more
wiley   +1 more source

Clandestinovirus: A Giant Virus With Chromatin Proteins and a Potential to Manipulate the Cell Cycle of Its Host Vermamoeba vermiformis. [PDF]

open access: yesFront Microbiol, 2021
Rolland C   +5 more
europepmc   +1 more source

A giant virus forms a specialized subcellular environment within its amoeba host for efficient translation. [PDF]

open access: yesNat Microbiol
Zhang R   +7 more
europepmc   +1 more source

Family Game Show-style Didactic for Teaching Nervous System Disorders during Emergency Medicine Training [PDF]

open access: yes, 2020
Boysen Osborn, Megan   +3 more
core  

Home - About - Disclaimer - Privacy